Moreover, it is important to note that while TMEM97 has been shown to be an oncogene in colon, gastric, and breast cancers, evidence also exists for its potential tumor-suppressor role in pancreatic and prostate cancers.18 This evidence concerns the gene TMEM97 and prostate cancer.